BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2009
View Archived Issues
Snapshots of studies of CXA-101 presented at ICAAC: I
Read More
Anti-sclerostin antibody given with zoledronic acid efficacious in osteoporosis models
Read More
Fully human anti-DKK1 monoclonal antibody increases bone formation in osteopenia models
Read More
Synthetic pleuromutilin derivatives evaluated by Nabriva for the treatment of bacterial infections
Read More
LEAD Therapeutics discloses PARP inhibitors for cancer and other conditions
Read More
Allergan describes alpha2B-adrenoceptor agonists for pain and other conditions
Read More
Novel estrogen receptor beta agonists reported by Wyeth for the treatment of RA
Read More
Quidel cleared to add 2009 H1N1 influenza A virus reactivity to QuickVue package insert
Read More
Enzo Life Sciences introduces novel live-cell imaging kit for nuclear components
Read More
PF-04287881 shows potent in vitro and in vivo antibacterial activity in respiratory tract infections
Read More
S1P1 receptor agonists for the treatment of MS identified by GSK
Read More
AEterna Zentaris completes phase I oral AEZS-112 study in cancer
Read More
Stallergenes reports results of phase IIb/III trial of recombinant allergen of birch pollen
Read More
Enzo Biochem and NIH collaborate on autoimmune uveitis treatment
Read More
Maxygen confirms completion of joint venture with Astellas
Read More
Provectus completes treatment in phase II PV-10 trial for metastatic melanoma
Read More
Dor BioPharma receives NIH grant to develop thermostable vaccines
Read More
Cytokinetics presents progress and expansion of development programs
Read More
AMDL stockholders approve name change to Radient Pharmaceuticals
Read More
FDA grants priority review for Velcade-based therapy in multiple myeloma
Read More
AGI Therapeutics completes data analysis of phase III Rezular studies
Read More
King Pharmaceuticals launches Embeda for moderate to severe pain
Read More
Interim data from phase II trial of 5% Human Albumin Grifols in AD disclosed
Read More
Vitae initiates phase I renin inhibitor trial
Read More
Prolor Biotech commences phase I clinical trial for its long-acting growth hormone
Read More